Double maintains 1 strategies that include AMLX - Amylyx Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RGNX | 46.02% | $376.88M | -51.30% | 0.00% |
DNLI | 43.71% | $2.09B | -21.52% | 0.00% |
ACLX | 41.55% | $3.17B | +15.70% | 0.00% |
CRBU | 41.22% | $72.01M | -78.13% | 0.00% |
OCUL | 39.83% | $1.12B | +24.73% | 0.00% |
RCKT | 39.35% | $746.43M | -69.23% | 0.00% |
CMPS | 39.15% | $351.90M | -51.78% | 0.00% |
CRSP | 38.77% | $3.08B | -30.39% | 0.00% |
ATXS | 38.10% | $238.72M | -56.53% | 0.00% |
NTLA | 37.59% | $841.09M | -66.80% | 0.00% |
IMNM | 37.14% | $649.11M | -51.87% | 0.00% |
ELVN | 37.13% | $903.80M | -21.38% | 0.00% |
ROIV | 37.08% | $7.59B | -4.40% | 0.00% |
ALEC | 36.48% | $116.99M | -77.71% | 0.00% |
FATE | 36.24% | $119.19M | -74.51% | 0.00% |
SITE | 36.00% | $5.41B | -22.90% | 0.00% |
ARWR | 35.79% | $1.79B | -40.99% | 0.00% |
CRNX | 35.63% | $2.87B | -36.08% | 0.00% |
TWST | 35.59% | $1.85B | -27.26% | 0.00% |
APGE | 35.58% | $2.18B | -29.93% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PHYS | -<0.01% | - | - | 0.00% |
CYD | -0.09% | $646.82M | +107.21% | 2.07% |
DG | -0.10% | $20.16B | -34.97% | 2.61% |
CARV | -0.14% | $7.17M | -15.93% | 0.00% |
AMR | -0.16% | $1.48B | -60.49% | 0.00% |
LITB | 0.18% | $22.23M | -73.00% | 0.00% |
BBD | 0.19% | $14.43B | +14.75% | 1.45% |
PG | 0.19% | $369.64B | -5.51% | 2.59% |
PPC | -0.21% | $11.16B | +43.07% | 0.00% |
AQB | 0.24% | $2.55M | -64.90% | 0.00% |
SITC | 0.24% | $631.96M | +10.96% | 1.04% |
BNED | 0.28% | $358.59M | -63.79% | 0.00% |
CCRN | -0.35% | $459.29M | -6.16% | 0.00% |
GRVY | -0.36% | $448.20M | -13.45% | 0.00% |
CPB | -0.39% | $10.53B | -23.13% | 4.30% |
PEP | 0.41% | $178.84B | -27.45% | 4.16% |
MNOV | 0.42% | $72.10M | -3.92% | 0.00% |
PM | 0.44% | $264.14B | +70.28% | 3.26% |
HRZN | 0.51% | - | - | 17.18% |
HSY | -0.59% | $34.63B | -16.54% | 3.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 45.68% | $4.91B | 0.35% |
GNOM | 43.79% | $42.90M | 0.5% |
ARKG | 41.93% | $937.69M | 0.75% |
PINK | 41.85% | $133.42M | 0.5% |
IWC | 41.46% | $778.78M | 0.6% |
IBB | 40.04% | $5.12B | 0.45% |
KOMP | 39.49% | $2.10B | 0.2% |
CWB | 39.01% | $3.70B | 0.4% |
PTH | 38.50% | $99.72M | 0.6% |
IWO | 38.03% | $10.98B | 0.24% |
ICVT | 37.76% | $2.43B | 0.2% |
KAPR | 37.65% | $170.68M | 0.79% |
ARKK | 37.48% | $5.26B | 0.75% |
SCHA | 37.33% | $16.28B | 0.04% |
VTWO | 37.30% | $11.63B | 0.07% |
IWM | 36.99% | $60.69B | 0.19% |
VXF | 36.30% | $20.57B | 0.05% |
NUSC | 36.29% | $1.10B | 0.31% |
VBK | 36.28% | $17.57B | 0.07% |
PBE | 36.26% | $214.14M | 0.58% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -10.99% | $27.34M | +82.40% | 0.00% |
CBOE | -10.22% | $24.26B | +27.97% | 1.07% |
PRT | -10.15% | $46.59M | -2.30% | 11.43% |
BG | -8.75% | $10.40B | -27.05% | 3.46% |
NOC | -8.60% | $69.46B | +1.65% | 1.73% |
ZCMD | -7.44% | $28.79M | -17.99% | 0.00% |
MGPI | -7.41% | $699.63M | -60.41% | 1.41% |
EQNR | -5.90% | $62.97B | -14.75% | 5.97% |
LZ | -5.81% | $1.64B | -9.52% | 0.00% |
MO | -4.59% | $100.11B | +32.36% | 6.99% |
TSN | -4.13% | $19.31B | -7.29% | 3.58% |
CME | -3.73% | $102.47B | +36.41% | 3.79% |
DOGZ | -3.69% | $208.91M | +169.02% | 0.00% |
FUBO | -3.46% | $918.74M | +110.16% | 0.00% |
ACHC | -3.25% | $2.20B | -66.80% | 0.00% |
FMTO | -3.23% | $59.28M | -99.91% | 0.00% |
HCA | -2.95% | $85.09B | +8.28% | 0.76% |
AEP | -2.94% | $55.92B | +14.27% | 4.42% |
HIHO | -2.86% | $7.92M | -12.83% | 3.89% |
AMPY | -2.85% | $116.57M | -53.61% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.40% | $384.38M | 1.43% |
VIXY | -26.52% | $111.81M | 0.85% |
TAIL | -21.50% | $161.11M | 0.59% |
CARY | -11.56% | $347.36M | 0.8% |
CTA | -11.55% | $1.03B | 0.76% |
IVOL | -10.73% | $357.81M | 1.02% |
FXY | -8.79% | $931.15M | 0.4% |
TPMN | -8.02% | $31.28M | 0.65% |
WEAT | -7.49% | $116.89M | 0.28% |
SPTS | -7.47% | $5.85B | 0.03% |
UNG | -7.46% | $355.31M | 1.06% |
DBE | -5.29% | $46.18M | 0.77% |
UUP | -4.91% | $282.84M | 0.77% |
USDU | -4.75% | $175.83M | 0.5% |
SCHO | -4.65% | $10.91B | 0.03% |
UTWO | -4.64% | $388.40M | 0.15% |
IBTG | -4.43% | $1.88B | 0.07% |
BUXX | -4.33% | $284.27M | 0.25% |
UGA | -4.21% | $70.71M | 0.97% |
DBA | -4.10% | $824.46M | 0.93% |
Finnhub
Amylyx Pharmaceuticals Inc: * AMYLYX PHARMACEUTICALS ANNOUNCES POSITIVE LONG-TERMRESULTS FROMPHASE 2 HELIOS CLINICAL TRIAL OF AMX0035 IN PEOPLE WITH WOLFRAMSYNDROME *...
Finnhub
Amylyx Pharmaceuticals, Inc. announced positive Week 48 data from the Phase 2 open-label HELIOS clinical trial of AMX0035 in adults living with Wolfram syndrome. These results were presented at the...
SeekingAlpha
The following slide deck was published by Amylyx Pharmaceuticals, Inc.
SeekingAlpha
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsLindsey Allen - Vice President...
Finnhub
Amylyx Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 35.91 million compared to USD 118.79...
Finnhub
Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia ; completion of...
Current Value
$4.891 Year Return
Current Value
$4.891 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USL | -0.12% | $39.62M | 0.85% |
FTSM | -0.13% | $6.59B | 0.45% |
SHY | 0.22% | $24.26B | 0.15% |
TFLO | 0.25% | $7.11B | 0.15% |
CGSM | 0.25% | $656.68M | 0.25% |
TDTT | 0.33% | $2.41B | 0.18% |
AGZD | 0.34% | $126.97M | 0.23% |
OILK | 0.41% | $59.97M | 0.69% |
GSG | 0.43% | $889.57M | 0.75% |
IBTI | -0.46% | $998.40M | 0.07% |
PDBC | -0.55% | $4.30B | 0.59% |
BSV | -0.55% | $38.36B | 0.03% |
DBC | -0.56% | $1.14B | 0.87% |
COMT | -0.57% | $589.59M | 0.48% |
FMHI | -0.62% | $752.99M | 0.7% |
SHM | 0.65% | $3.37B | 0.2% |
XHLF | 0.71% | $1.34B | 0.03% |
IBTJ | 0.72% | $654.10M | 0.07% |
SHYM | -0.77% | $323.40M | 0.35% |
FTSD | -0.77% | $212.47M | 0.25% |